Multifunctional cerium oxide nanozymes with high ocular surface retention for dry eye disease treatment achieved by restoring redox balance
Authors:
- 11 July 2024
- journal article
- research article
- Published by Elsevier in Acta Biomaterialia
- Vol. 185, 441-455
Abstract
No abstract availableKeywords
This publication has 43 references indexed in Scilit:
- Hyperammonemia induces microglial NLRP3 inflammasome activation via mitochondrial oxidative stress in hepatic encephalopathyBiomedical Journal, 2023
- Smart contact lens systems for ocular drug delivery and therapyAdvanced Drug Delivery Reviews, 2023
- Cyclosporin A improves the hyperosmotic response in an experimental dry eye model by inhibiting the HMGB1/TLR4/NF-κB signaling pathwayExperimental Eye Research, 2023
- Nano-based eye drop: Topical and noninvasive therapy for ocular diseasesAdvanced Drug Delivery Reviews, 2023
- In Situ Forming Hydrogel as a Tracer and Degradable Lacrimal Plug for Dry Eye TreatmentAdvanced Healthcare Materials, 2022
- Dry Eye DiseaseJAMA, 2022
- Dendrimer-assisted boronate affinity cellulose foams for the efficient and selective separation of glycoproteinsCarbohydrate Polymers, 2021
- Characterization of a nitric oxide (NO) donor molecule and cerium oxide nanoparticle (CNP) interactions and their synergistic antimicrobial potential for biomedical applicationsJournal of Colloid and Interface Science, 2020
- Phenylboronic acid-tethered chondroitin sulfate-based mucoadhesive nanostructured lipid carriers for the treatment of dry eye syndromeActa Biomaterialia, 2019
- Phenylboronic acid modified mucoadhesive nanoparticle drug carriers facilitate weekly treatment of experimentallyinduced dry eye syndromeNano Research, 2014